Epidermal growth factor receptor (EGFR)—tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer

 : OBJECTIVES: To clarify survival outcomes and prognostic factors of patients receiving epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitors (TKIs) as first-line treatment for postoperative recurrence. METHODS: A retrospective chart review was performed to identify consecutive patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriya, Tetsuji, Hamaji, Masatsugu, Yoshizawa, Akihiko, Miyata, Ryo, Noguchi, Misa, Tamari, Shigeyuki, Chiba, Naohisa, Miyamoto, Hideaki, Toyazaki, Toshiya, Tanaka, Satona, Yamada, Yoshito, Yutaka, Yojiro, Nakajima, Daisuke, Ohsumi, Akihiro, Menju, Toshi, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thoracic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860430/
https://www.ncbi.nlm.nih.gov/pubmed/34652430
http://dx.doi.org/10.1093/icvts/ivab283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860430/
https://www.ncbi.nlm.nih.gov/pubmed/34652430
http://dx.doi.org/10.1093/icvts/ivab283

Ejemplares similares